- Home
- / BioPerfectus
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BioPerfectus financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥77.8
2024-10-29
Market Capitalization
¥4.4 B
2024-10-29
Revenue
¥324.6 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 225.4M | 281.3M | 1.5B | 2.3B | 4.3B | 372.0M | 324.6M |
| Cost of goods sold | 42.3M | 52.7M | 389.9M | 876.3M | 2.2B | 145.5M | 132.0M |
| Gross profit | 187.3M | 234.6M | 1.3B | 1.9B | 3.3B | 249.6M | 210.9M |
| Gross profit margin, % | 83.4% | 89.6% | 83.8% | 77.2% | 67.1% | 65.0% | |
| Operating expense total | 114.2M | 132.2M | 413.3M | 603.9M | 825.7M | 441.5M | 256.7M |
| Depreciation and amortization | 13.9M | 17.8M | 22.6M | 34.1M | 223.7M | 147.8M | 60.4M |
| EBITDA | 73.1M | 102.3M | 926.0M | 1.3B | 2.5B | (194.6M) | (52.8M) |
| EBITDA margin, % | 36.4% | 61.9% | 57.7% | 58.1% | -52.3% | -16.3% | |
| EBIT | 64.9M | 90.8M | 955.7M | 1.4B | 2.1B | (425.0M) | (27.4M) |
| EBIT margin, % | 32.3% | 63.9% | 59.0% | 48.8% | -114.2% | -8.5% | |
| Interest income | 4.0M | 7.8M | 26.8M | 39.2M | 56.0M | 39.8M | |
| Interest expense | 83.0K | 4.0M | 5.3M | 6.9M | 7.7M | ||
| Pre tax profit | 73.0M | 94.7M | 961.0M | 1.4B | 2.1B | (375.7M) | 4.2M |
| Income tax expense | 9.1M | 10.9M | 141.4M | 198.6M | 310.8M | (1.9M) | 6.2M |
| Net Income | 63.8M | 83.8M | 819.6M | 1.2B | 1.8B | (373.8M) | (2.0M) |